Stephen J. Tulipano
2022 - Stoke Therapeutics
In 2022, Stephen J. Tulipano earned a total compensation of $2.3M as Chief Financial Officer at Stoke Therapeutics, a 25% decrease compared to previous year.
Compensation breakdown
| Bonus | $17,210 |
|---|---|
| Non-Equity Incentive Plan | $154,890 |
| Option Awards | $1,697,431 |
| Salary | $436,800 |
| Other | $10,192 |
| Total | $2,316,523 |
Tulipano received $1.7M in option awards, accounting for 73% of the total pay in 2022.
Tulipano also received $17.2K in bonus, $154.9K in non-equity incentive plan, $436.8K in salary and $10.2K in other compensation.
Rankings
In 2022, Stephen J. Tulipano's compensation ranked 1,554th out of 5,717 executives tracked by ExecPay. In other words, Tulipano earned more than 72.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,554 out of 5,717 | 73rd |
Division Manufacturing | 788 out of 3,111 | 75th |
Major group Chemicals And Allied Products | 307 out of 1,410 | 78th |
Industry group Drugs | 285 out of 1,311 | 78th |
Industry Pharmaceutical Preparations | 201 out of 957 | 79th |
Source: SEC filing on September 28, 2023.
Tulipano's colleagues
We found two more compensation records of executives who worked with Stephen J. Tulipano at Stoke Therapeutics in 2022.